Form 8-K - Current report:
SEC Accession No. 0001140361-23-026845
Filing Date
2023-05-26
Accepted
2023-05-26 09:00:25
Documents
13
Period of Report
2023-05-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K brhc20053532_8k.htm   iXBRL 8-K 104649
  Complete submission text file 0001140361-23-026845.txt   299734

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mrk-20230523.xsd EX-101.SCH 4890
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrk-20230523_def.xml EX-101.DEF 18767
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrk-20230523_lab.xml EX-101.LAB 29095
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrk-20230523_pre.xml EX-101.PRE 21123
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc20053532_8k_htm.xml XML 9337
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Filer) CIK: 0000310158 (see all company filings)

EIN.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06571 | Film No.: 23963266
SIC: 2834 Pharmaceutical Preparations